Mexico · Delayed Price · Currency is MXN Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of MXN 177.12 billion. The enterprise value is 105.96 billion.
| Market Cap | 177.12B |
| Enterprise Value | 105.96B |
Important Dates
The last earnings date was Thursday, November 6, 2025.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 390.58M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 6.53% |
| Owned by Institutions (%) | 72.78% |
| Float | 364.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.33 |
| PB Ratio | 1.03 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.85 |
| EV / Sales | 2.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.18 |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.93 |
| Quick Ratio | 3.30 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -144.29 |
Financial Efficiency
Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -18.58%.
| Return on Equity (ROE) | -29.32% |
| Return on Assets (ROA) | -15.49% |
| Return on Invested Capital (ROIC) | -18.58% |
| Return on Capital Employed (ROCE) | -33.13% |
| Revenue Per Employee | 7.06M |
| Profits Per Employee | -9.85M |
| Employee Count | 5,800 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 15.32 |
Taxes
| Income Tax | -678.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.35% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -59.35% |
| 50-Day Moving Average | 477.32 |
| 200-Day Moving Average | 561.20 |
| Relative Strength Index (RSI) | 41.09 |
| Average Volume (20 Days) | 7,263 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Moderna had revenue of MXN 40.94 billion and -57.15 billion in losses. Loss per share was -147.68.
| Revenue | 40.94B |
| Gross Profit | -63.57B |
| Operating Income | -63.52B |
| Pretax Income | -57.83B |
| Net Income | -57.15B |
| EBITDA | -59.70B |
| EBIT | -63.52B |
| Loss Per Share | -147.68 |
Balance Sheet
The company has 82.61 billion in cash and 12.58 billion in debt, giving a net cash position of 70.03 billion.
| Cash & Cash Equivalents | 82.61B |
| Total Debt | 12.58B |
| Net Cash | 70.03B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 171.13B |
| Book Value Per Share | 438.80 |
| Working Capital | 90.19B |
Cash Flow
In the last 12 months, operating cash flow was -36.28 billion and capital expenditures -12.38 billion, giving a free cash flow of -48.66 billion.
| Operating Cash Flow | -36.28B |
| Capital Expenditures | -12.38B |
| Free Cash Flow | -48.66B |
| FCF Per Share | n/a |
Margins
Gross margin is -155.29%, with operating and profit margins of -155.15% and -139.61%.
| Gross Margin | -155.29% |
| Operating Margin | -155.15% |
| Pretax Margin | -141.26% |
| Profit Margin | -139.61% |
| EBITDA Margin | -145.83% |
| EBIT Margin | -155.15% |
| FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.31% |
| Shareholder Yield | -1.31% |
| Earnings Yield | -32.27% |
| FCF Yield | -27.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |